Abeona regains Nasdaq compliance with minimum bid price requirement

ABEONA THERAPEUTICS INC.

Received Nasdaq notification on July 19, 2022 confirming compliance with Listing Rule 5550(a)(2).
Minimum $1.00 closing bid price was maintained for 10 consecutive trading days through July 18, 2022.
Matter is now closed; common stock will continue trading on Nasdaq Capital Market.
Press release issued July 20, 2022 announcing the compliance regain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.